Can a special drink help tame blood sugar in type 2 diabetes?

NCT ID NCT07666581

Not yet recruiting Disease control Sponsor: Hospital Universitario San Ignacio Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test whether replacing breakfast and a snack with a diabetes-specific nutritional drink (Glucerna) helps people with type 2 diabetes and obesity keep their blood sugar in a healthy range more often. About 198 adults will be randomly assigned to either the drink-based diet or a standard low-calorie diet for three months. Researchers will track blood sugar levels, weight, and other health measures to see if the drink makes a meaningful difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Glucerna (a diabetes-specific nutritional drink)
What this could lead to: If successful, this could show that replacing meals with a specialized nutritional drink helps people with type 2 diabetes and obesity better manage their blood sugar levels.
What could go wrong: This is a small, early-stage study that hasn't started recruiting yet. The results may not apply to everyone, and the drink is not a cure—it's a dietary aid that may or may not improve blood sugar control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY & OVERWEIGHT TIME IN RANGE TYPE 2 DIABETES

Contacts and locations

Locations

Hospital Universitario San Ignacio

Bogotá, Cundinamarca, 111021, Colombia

More trials for these conditions

Other studies related to the condition(s) this trial covers.